אוסטרליה - אנגלית - Department of Health (Therapeutic Goods Administration)

aspen pharma pty ltd - digoxin, quantity: 250 microgram - tablet, uncoated - excipient ingredients: magnesium stearate; rice starch; lactose monohydrate; oxidised maize starch; hydrolysed maize starch - congestive heart failure - sigmaxin is useful regardless of whether the failure is predominantly of the left or right ventricle, or involves both sides of the heart. it is particularly useful in heart failure resulting from chronic overload (hypertension, valvular lesions, atherosclerotic heart disease) in which the supply of energy is not impaired. sigmaxin does not cause major benefit in situations in which the metabolic energy supply is compromised as in thyrotoxicosis, hypoxia, and severe thiamine deficiency. atrial fibrillation - because sigmaxin depresses conduction in the atrioventricular bundle, producing a slower ventricular beat, it is valuable in atrial fibrillation. it will frequently convert atrial flutter into fibrillation and, upon withdrawal of the drug, normal sinus rhythm may be restored. paroxysmal atrial tachycardia - sigmaxin may relieve or prevent an attack, but its use in paroxysmal ventricular tachycardia is dangerous.

אוסטרליה - אנגלית - Department of Health (Therapeutic Goods Administration)

aspen pharma pty ltd - digoxin, quantity: 0.0625 microgram - tablet, uncoated - excipient ingredients: lactose monohydrate; rice starch; magnesium stearate; hydrolysed maize starch; povidone; indigo carmine; oxidised maize starch - congestive heart failure - sigmaxin is useful regardless of whether the failure is predominantly of the left or right ventricle, or involves both sides of the heart. it is particularly useful in heart failure resulting from chronic overload (hypertension, valvular lesions, atherosclerotic heart disease) in which the supply of energy is not impaired. sigmaxin does not cause major benefit in situations in which the metabolic energy supply is compromised as in thyrotoxicosis, hypoxia, and severe thiamine deficiency. atrial fibrillation - because sigmaxin depresses conduction in the atrioventricular bundle, producing a slower ventricular beat, it is valuable in atrial fibrillation. it will frequently convert atrial flutter into fibrillation and, upon withdrawal of the drug, normal sinus rhythm may be restored. paroxysmal atrial tachycardia - sigmaxin may relieve or prevent an attack, but its use in paroxysmal ventricular tachycardia is dangerous.

מצרים - אנגלית - EDA (Egyptian Drug Authority)

sigma pharmaceutical industries - powder for oral suspension - 250 mg/5ml

מצרים - אנגלית - EDA (Egyptian Drug Authority)

sigma pharmaceutical industries - coated tablet - 375 mg

מצרים - אנגלית - EDA (Egyptian Drug Authority)

sigma pharmaceutical industries - tablet - 3 mg

מצרים - אנגלית - EDA (Egyptian Drug Authority)

sigma pharmaceutical industries - sustained release capsule - 75 mg

מצרים - אנגלית - EDA (Egyptian Drug Authority)

sigma pharmaceutical industries - tablet - 20 mg

מצרים - אנגלית - EDA (Egyptian Drug Authority)

sigma pharmaceutical industries - tablet - 40 mg

מצרים - אנגלית - EDA (Egyptian Drug Authority)

sigma tec pharmaceutical industries-egypt - eye drops - 0.03 %

אוסטרליה - אנגלית - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - hydrocortisone acetate, quantity: 10 mg/g - ointment - excipient ingredients: hard paraffin; liquid paraffin; wool fat; white soft paraffin - topical corticosteroid therapy for non-infective inflammatory conditions of the skin eg. eczema, dermatitis.